Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Heparinase high-yielding strain and breeding method thereof

A high-yielding strain, heparinase technology, applied in the biological field, can solve the problems of wasting manpower and material resources, and achieve the effect of increasing yield and saving manpower

Active Publication Date: 2017-09-22
SHENZHEN HEPALINK PHARMA GRP CO LTD
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the screening method of heparinase-producing microorganisms mainly adopts the domestication method of gradually replacing the original carbon source of the microbial screening medium with heparin, and specifically enriches the microbial strains that have the ability to lyse heparin, and then monitors the enriched culture medium by the Azure A method. Changes in the content of heparin in the medium, the samples containing the strains that can utilize heparin were initially screened, and each colony in the sample was smeared, and a single colony was picked for re-screening. The crude extract is crushed, and the enzyme activity is determined by the Azure A method to determine whether it is a heparanase-producing microorganism. However, this screening method needs to try a variety of formula media, which wastes a lot of manpower and material resources. Therefore, to explore a A simple and rapid method for screening heparanase-producing microorganisms is of great significance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heparinase high-yielding strain and breeding method thereof
  • Heparinase high-yielding strain and breeding method thereof
  • Heparinase high-yielding strain and breeding method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0033] Example: Add 1.0 g of the collected soil sample into a test tube containing 10 mL of sterile saline and shake well, then take 5 mL of the suspension and add it to a conical flask containing 25 mL of enrichment medium, shake at 200 r / min at 37 °C The flasks were cultured for 2 days. Dilute the enriched cultured bacterial solution with sterile normal saline gradient to an appropriate dilution, and take an appropriate amount of bacterial solution and spread it on the primary screening plate. After the strains on the plate grow to a certain size, wash off the colonies with distilled water, add 2% protamine solution, and place at 37°C for 1 hour. Pour off the protamine solution, wash it with distilled water, and place it at room temperature for a period of time, and a transparent circle will appear at the place where the original colony grew. Select the strain with a larger ratio of transparent circle to colony diameter and transfer it to the seed medium. Pick the colony w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a heparanase high-yielding strain. The strain is Raoultella SP.NX-TZ-3,15. The strain is already preserved in a preserve department specified by the State Intellectual Property Office, the preserve date is March 6 th, 2017, the preserve department is the China Common Microorganism Strain Preserve and Management center, and the preserve serial number is CGMCC No.13723. In breeding of the heparanase high-yielding strain, precipitation generated through the reaction of protamine and heparin is utilized as an indicator, heparanase generated through microorganisms are subjected to a reaction of cracking heparin to make the precipitation disappear, transparent rings are generated around thalli, further an effect of directly indicating heparanase source microorganism strains is achieved, through secondary screening and a 16S r DNA method, the heparanase yielding strain SP.NX-TZ-3,15 is identified. In the heparanase high-yielding strain, the disadvantages that in an original screening method of heparanase source microorganisms, time, labor and materials are consumed is solved, the precipitation generated through the reaction of protamine and heparin is utilized as the indicator, and thus the labor, materials and time are sharply saved.

Description

[technical field] [0001] The invention belongs to the field of biotechnology, and in particular relates to a high-yield heparanase strain Raoultella SP.NX-TZ-3,15 and a breeding method thereof. [Background technique] [0002] Heparinase or heparin lyase is a class of proteins that can specifically cleave the glycosidic bonds of heparin and heparan sulfate. Heparinase was first discovered from Flavobacterium heparinus, a microorganism that can produce oligosaccharides using heparin, and it is mainly used clinically to prevent thrombosis or as an anticoagulant drug in vitro. [0003] Currently, three heparinases have been identified from Flavobacterium heparinus: heparinase I (heparinase, EC 4.2.2.7), heparinase II (heparinase II), and heparinase III (heparinase, EC 4.2. 2.8). Heparanase I mainly cleaves heparin, heparanase III mainly cleaves heparan sulfate, and heparanase II cleaves both heparin and heparan sulfate. Flavobacterium heparinus is mainly used in the productio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N1/20C12Q1/68C12Q1/04C12R1/01
CPCC12N1/20C12Q1/686C12N1/205C12R2001/01C12Q2565/125
Inventor 赵丽青刘文丽蒋莹子
Owner SHENZHEN HEPALINK PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products